Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.

Nicolas Verheyen; Astrid Fahrleitner-Pammer; Burkert Pieske; Andreas Meinitzer; Evgeny Belyavskiy; Julia Wetzel; Martin Gaksch; Martin R Grübler; Cristiana Catena; Leonardo A Sechi; Adriana J Van Ballegooijen; Vincent M Brandenburg; Hubert Scharnagl; Sabine Perl; Helmut Brussee; Winfried März; Stefan Pilz; Andreas Tomaschitz

doi:10.1097/HJH.0000000000001004

Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.

Nicolas Verheyen
, Astrid Fahrleitner-Pammer
, Burkert Pieske
, Andreas Meinitzer
, Evgeny Belyavskiy
, Julia Wetzel
, Martin Gaksch (Co-author)
, Martin R Grübler
, Cristiana Catena
, Leonardo A Sechi
, Adriana J Van Ballegooijen
, Vincent M Brandenburg
, Hubert Scharnagl
, Sabine Perl
, Helmut Brussee
, Winfried März
, Stefan Pilz
, Andreas Tomaschitz

Research output: Contribution to journal › Original Article › peer-review

21 Citations (Web of Science)

Original language	English
Pages (from-to)	177-186
Journal	JOURNAL OF HYPERTENSION
Volume	34
Issue number	9
DOIs	https://doi.org/10.1097/HJH.0000000000001004
Publication status	Published - 2016

Keywords

PLACEBO-CONTROLLED TRIAL
CARDIOVASCULAR-DISEASE
ANGIOTENSIN-II
SERUM-CALCIUM
HYPERTENSION
SECRETION
MORTALITY
RESPONSES
ADENOMA
RANGE

Access to Document

10.1097/HJH.0000000000001004

Cite this

Verheyen, N., Fahrleitner-Pammer, A., Pieske, B., Meinitzer, A., Belyavskiy, E., Wetzel, J., Gaksch, M., Grübler, M. R., Catena, C., Sechi, L. A., Van Ballegooijen, A. J., Brandenburg, V. M., Scharnagl, H., Perl, S., Brussee, H., März, W., Pilz, S., & Tomaschitz, A. (2016). Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial. JOURNAL OF HYPERTENSION , 34(9), 177-186. https://doi.org/10.1097/HJH.0000000000001004

Verheyen, Nicolas ; Fahrleitner-Pammer, Astrid ; Pieske, Burkert et al. / Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial. In: JOURNAL OF HYPERTENSION 2016 ; Vol. 34, No. 9. pp. 177-186.

@article{aab5bcc579a449ca8bb136c4c54eb824,

title = "Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.",

keywords = "PLACEBO-CONTROLLED TRIAL, CARDIOVASCULAR-DISEASE, ANGIOTENSIN-II, SERUM-CALCIUM, HYPERTENSION, SECRETION, MORTALITY, RESPONSES, ADENOMA, RANGE",

author = "Nicolas Verheyen and Astrid Fahrleitner-Pammer and Burkert Pieske and Andreas Meinitzer and Evgeny Belyavskiy and Julia Wetzel and Martin Gaksch and Gr{\"u}bler, \{Martin R\} and Cristiana Catena and Sechi, \{Leonardo A\} and \{Van Ballegooijen\}, \{Adriana J\} and Brandenburg, \{Vincent M\} and Hubert Scharnagl and Sabine Perl and Helmut Brussee and Winfried M{\"a}rz and Stefan Pilz and Andreas Tomaschitz",

year = "2016",

doi = "10.1097/HJH.0000000000001004",

language = "English",

volume = "34",

pages = "177--186",

journal = "JOURNAL OF HYPERTENSION ",

issn = "0263-6352",

number = "9",

}

Verheyen, N, Fahrleitner-Pammer, A, Pieske, B, Meinitzer, A, Belyavskiy, E, Wetzel, J, Gaksch, M, Grübler, MR, Catena, C, Sechi, LA, Van Ballegooijen, AJ, Brandenburg, VM, Scharnagl, H, Perl, S, Brussee, H, März, W, Pilz, S & Tomaschitz, A 2016, 'Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.', JOURNAL OF HYPERTENSION , vol. 34, no. 9, pp. 177-186. https://doi.org/10.1097/HJH.0000000000001004

Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial. / Verheyen, Nicolas; Fahrleitner-Pammer, Astrid; Pieske, Burkert et al.
In: JOURNAL OF HYPERTENSION , Vol. 34, No. 9, 2016, p. 177-186.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.

AU - Verheyen, Nicolas

AU - Fahrleitner-Pammer, Astrid

AU - Pieske, Burkert

AU - Meinitzer, Andreas

AU - Belyavskiy, Evgeny

AU - Wetzel, Julia

AU - Gaksch, Martin

AU - Grübler, Martin R

AU - Catena, Cristiana

AU - Sechi, Leonardo A

AU - Van Ballegooijen, Adriana J

AU - Brandenburg, Vincent M

AU - Scharnagl, Hubert

AU - Perl, Sabine

AU - Brussee, Helmut

AU - März, Winfried

AU - Pilz, Stefan

AU - Tomaschitz, Andreas

PY - 2016

Y1 - 2016

KW - PLACEBO-CONTROLLED TRIAL

KW - CARDIOVASCULAR-DISEASE

KW - ANGIOTENSIN-II

KW - SERUM-CALCIUM

KW - HYPERTENSION

KW - SECRETION

KW - MORTALITY

KW - RESPONSES

KW - ADENOMA

KW - RANGE

U2 - 10.1097/HJH.0000000000001004

DO - 10.1097/HJH.0000000000001004

M3 - Original Article

C2 - 27379537

SN - 0263-6352

VL - 34

SP - 177

EP - 186

JO - JOURNAL OF HYPERTENSION

JF - JOURNAL OF HYPERTENSION

IS - 9

ER -

Verheyen N, Fahrleitner-Pammer A, Pieske B, Meinitzer A, Belyavskiy E, Wetzel J et al. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial. JOURNAL OF HYPERTENSION . 2016;34(9):177-186. doi: 10.1097/HJH.0000000000001004